GW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises

Canada News News

GW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises
Canada Latest News,Canada Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

GW Pharmaceuticals PLC undefined shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy...

GW Pharmaceuticals PLC GWPH, +0.68% shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy drug, Epidiolex. The company reported a first-quarter net loss of $8 million, or 2 cents a share, compared with a loss of $50.1 million, or 14 cents a share, a year ago. Revenue rose to $120.6 million from $39.

2 million in the year-ago period. The company's most popular drug, a cannabis-derived medicine used to treat epilepsy, logged sales of $116.1 million, topping analyst expectations of $106.9 million, according to FactSet's survey. Wall Street expected an adjusted net loss of 7 cents a share on sales of $108.4 million. GW Pharma stock has inched up 4.7% this year as the benchmark S&P 500 index SPX, +0.01% has fallen 9.3%.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

California's coronavirus outlook worse than researchers expected, as cases, deaths riseCalifornia's coronavirus outlook worse than researchers expected, as cases, deaths riseCalifornia's coronavirus outlook worse than researchers expected as cases, deaths rise
Read more »

Americans expect stocks to gain in the next year, even as their own financial conditions worsen | Markets InsiderAmericans expect stocks to gain in the next year, even as their own financial conditions worsen | Markets InsiderThe perceived probability that US stock prices will be higher in the next 12 months surged to a survey high of 51.8% in April from 47.7% in Marc...
Read more »

Stocks rise as more economies emerge from lockdownStocks rise as more economies emerge from lockdownAsian shares followed Wall Street higher on Monday as investors looked ahead to more countries restarting their economies, even as some reported an unwelcome pick up in new coronavirus cases.
Read more »

Dow falls nearly 250 points to start Monday trade as investors face effects of lockdown reopenings and U.S.-China tensionDow falls nearly 250 points to start Monday trade as investors face effects of lockdown reopenings and U.S.-China tensionU.S. stock indexes fell to start Monday trade as investors contended with heightened rhetoric between the U.S. and China and signs of rising cases as...
Read more »

European markets head for positive open as more lockdown restrictions are liftedEuropean markets head for positive open as more lockdown restrictions are liftedEuropean stocks are expected to open in positive territory on Monday as lockdown lifting continues throughout Europe.
Read more »

White House advisers expect unemployment rates to continue to rise - Business InsiderWhite House advisers expect unemployment rates to continue to rise - Business InsiderAs one advisor said the numbers for May are likely to be 'very difficult,' another said the next jobs report could see unemployment rates nearing 20%.
Read more »



Render Time: 2025-04-05 13:05:31